Cediranib in combination with fulvestrant in hormone-sensitive metastatic breast cancer: a randomized Phase 11 study

Hyams, D.; Chan, Arlene; de Oliveira, C.; Snyder, R.; Vinholes, J.; Audeh, M W.; Alencar, V.; Lombard, J.; Mookerjee, B.; Xu, J.; Brown, K.; Klein, P.

Access Status

Fulltext not available

Authors

Hyams, D.

Chan, Arlene

de Oliveira, C.

Snyder, R.

Vinholes, J.

Audeh, M W.

Alencar, V.

Lombard, J.

Mookerjee, B.

Xu, J.

Brown, K.

Klein, P.

Date

2013

Type

Journal Article

Metadata

Show full item record

Citation

Hyams, D. and Chan, A. and de Oliveira, C. and Snyder, R. and Vinholes, J. and Audeh, M W. and Alencar, V. et al. 2013. Cediranib in combination with fulvestrant in hormone-sensitive metastatic breast cancer: a randomized Phase 11 study. Investigational New Drugs. 31 (5): pp. 1345-1354.

Source Title

Investigational New Drugs